RxDoctor Payments Data

Leonid Poretsky, MD

Endocrinology, Diabetes & Metabolism · New York, NYNPI 1962491811

Payments from drug & device makers

$72,278in general payments, 2019–2025

Across 23 payments — averaging $3142.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$56K
  • Sanofi US Services Inc.$16K
  • Boehringer Ingelheim$42
  • Novo Nordisk$32
  • Amgen$21
  • Lilly USA, LLC$16

What the payments were for

  • Food & beverage$3733%
  • Education$7567%

General payments by program year

20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$72,278 in reported general payments places this provider in the 85th percentile of 804 endocrinology, diabetes & metabolism providers in New York.

See all endocrinology, diabetes & metabolism providers in New York

Medicare billing

Part B allowed, 2024
$61,651
Medicare patients
180
Services billed
1,320

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →